These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15699476)

  • 21. Randomization procedures in orthopaedic trials.
    Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
    Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomization in clinical trials.
    Webert KE
    Transfusion; 2007 Oct; 47(10):1753-4. PubMed ID: 17880598
    [No Abstract]   [Full Text] [Related]  

  • 23. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials referral resource. Current clinical trials in rhabdomyosarcoma.
    Anderson BD; Schoenfeldt M
    Oncology (Williston Park); 2005 Sep; 19(10):1319-20, 1330. PubMed ID: 16285226
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II trials in journal of clinical oncology.
    Cannistra SA
    J Clin Oncol; 2009 Jul; 27(19):3073-6. PubMed ID: 19451415
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized phase II studies and their ethics.
    Abratt RP; Reece WH; Enas NH; Stephens R
    J Clin Oncol; 2005 Dec; 23(36):9443. PubMed ID: 16361651
    [No Abstract]   [Full Text] [Related]  

  • 27. Importance of randomization in early clinical trials.
    Sargent D
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):249-51. PubMed ID: 19521327
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials and tribulations. Spiraling costs threaten gridlock.
    Malakoff D
    Science; 2008 Oct; 322(5899):210-3. PubMed ID: 18845742
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudo cluster randomization dealt with selection bias and contamination in clinical trials.
    Teerenstra S; Melis RJ; Peer PG; Borm GF
    J Clin Epidemiol; 2006 Apr; 59(4):381-6. PubMed ID: 16549260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life after DIAS II.
    Donnan GA; Davis SM
    Int J Stroke; 2007 Nov; 2(4):236-7. PubMed ID: 18705921
    [No Abstract]   [Full Text] [Related]  

  • 31. A parallel phase I/II clinical trial design for combination therapies.
    Huang X; Biswas S; Oki Y; Issa JP; Berry DA
    Biometrics; 2007 Jun; 63(2):429-36. PubMed ID: 17688495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside.
    Sakamoto J; Morita S
    Nagoya J Med Sci; 2007 Jan; 69(1-2):9-16. PubMed ID: 17378175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.
    Verberk WJ; Kroon AA; Kessels AG; Nelemans PJ; Van Ree JW; Lenders JW; Thien T; Bakx JC; Van Montfrans GA; Smit AJ; Beltman FW; De Leeuw PW
    Blood Press; 2005; 14(5):306-14. PubMed ID: 16257877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trials. When and why: the principle of randomization and double-blind method].
    de Giuli F
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):973-5. PubMed ID: 12497860
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 36. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-randomization and de-randomization in emergency medical research: new names and rigorous criteria for old methods.
    Hallstrom AP; Paradis NA
    Resuscitation; 2005 Apr; 65(1):65-9. PubMed ID: 15797277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-outcome design for randomized comparative phase II clinical trials.
    Hong S; Wang Y
    Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining heterogeneity in phase II trial designs may improve success in phase III.
    Tuma RS
    J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.